Outpatient Thermachoice endometrial balloon ablation: long-term, prognostic and quality-of-life measures.
Gynecol Obstet Invest
; 70(3): 145-8, 2010.
Article
em En
| MEDLINE
| ID: mdl-20558986
ABSTRACT
STUDY OBJECTIVE:
To evaluate short- and long-term treatment outcomes of outpatient local anaesthetic thermal balloon endometrial ablation (LA-TBEA) and identify any prognostic factors. STUDYDESIGN:
Prospective observational study in a UK teaching hospital involving 102 menorrhagic women undergoing LA-TBEA between 2001 and 2005. Women underwent either Gynecare® Thermachoice I (n = 51) or Thermachoice III (n = 51) TBEA performed in the outpatient setting under local anaesthesia without conscious sedation. The main outcome measures were treatment completion, pain and analgesia, duration of stay (from admission to discharge), duration of follow-up, primary treatment success and nature of any secondary treatment, menstrual symptoms and amenorrhoea, patient satisfaction, and quality of life.RESULTS:
TBEA was completed in 97% of women. Mean duration of stay was 8.0 h (95% CI 6.6-9.3). Mean follow-up was 30 months (95% CI 26-32). Secondary treatment with the levonorgestrel intrauterine system, repeat TBEA or hysterectomy occurred in 19/102 (19%). Overall, 50% of surgical re-interventions occurred by 19 months. There were high rates of amenorrhoea (29%) and treatment satisfaction (76%). Higher mean intrauterine ablation pressure was associated with increased treatment satisfaction.CONCLUSION:
TBEA can be successfully performed in the outpatient setting. Higher endometrial ablation pressure may improve long-term treatment outcome.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Endométrio
/
Técnicas de Ablação Endometrial
/
Procedimentos Cirúrgicos Ambulatórios
/
Temperatura Alta
/
Menorragia
Idioma:
En
Ano de publicação:
2010
Tipo de documento:
Article